Published in N Engl J Med on January 23, 1992
Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro. Clin Exp Immunol (1998) 0.81
Intravenous immunoglobulin in the management of lupus nephritis. Autoimmune Dis (2012) 0.80
Use of intravenous immunoglobulin in pediatric practice. Turk Pediatri Ars (2014) 0.75
Atypical C-ANCA following high dose intravenous immunoglobulin. J Clin Pathol (1999) 0.75
Clinical problem-solving. Testing, testing, testing.... N Engl J Med (1995) 3.45
Clinical problem-solving. Still hazy after all these years. N Engl J Med (1994) 2.69
Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet (1982) 2.34
Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc Natl Acad Sci U S A (1996) 1.71
Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A (1997) 1.61
The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA (1996) 1.53
Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum (1994) 1.50
Brucellosis in patients with heart disease: when should endocarditis be diagnosed? Cardiology (1990) 1.46
Thoughts on the proposed links between Behçet's disease and familial Mediterranean fever. Clin Exp Rheumatol (2002) 1.45
Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts. Eur J Neurol (2011) 1.42
Malignant melanoma in Turner's syndrome. Int J Dermatol (1993) 1.41
B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis. Clin Exp Immunol (2015) 1.40
"Treating through" hypersensitivity to co-trimoxazole in AIDS patients. Lancet (1990) 1.40
Familial Mediterranean fever in the "Chuetas" of Mallorca--origin in inquisition? Isr J Med Sci (1995) 1.39
Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest (1989) 1.36
Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum (2001) 1.17
Identification of new SLE-associated genes with a two-step Bayesian study design. Genes Immun (2009) 1.07
Liver involvement in giant cell arteritis. Clin Rheumatol (1993) 1.06
Dermatomyositis associated with the recurrence of transitional cell carcinomas and Kaposi's sarcoma. Clin Exp Rheumatol (1991) 1.05
Yellow nail syndrome: case report and review of the literature. Isr J Med Sci (1986) 1.02
Non-response to colchicine in FMF--definition, causes and suggested solutions. Clin Exp Rheumatol (2008) 1.02
HLA antigens in Reiter's syndrome in Israeli patients. J Rheumatol (1985) 0.97
Familial mediterranean fever - a review and update. Minerva Med (2001) 0.96
Unusual presentation of familial Mediterranean fever: role of genetic diagnosis. Ann Rheum Dis (2000) 0.96
Idiopathic sclerosing peritonitis in a man. J Clin Gastroenterol (1990) 0.95
Acute colchicine intoxication--possible role of erythromycin administration. J Rheumatol (1992) 0.94
Orbital mucosa-associated lymphoid tissue (MALT)-type lymphoma in a patient with relapsing polychondritis. Arthritis Rheum (2001) 0.93
Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies. Methods (1997) 0.92
Familial Mediterranean fever in the 'Chuetas' of Mallorca: a question of Jewish origin or genetic heterogeneity. Eur J Hum Genet (2000) 0.91
The effect of colchicine treatment on sperm production and function: a review. Hum Reprod (1998) 0.90
Idiopathic capillary leak syndrome complicated by massive rhabdomyolysis. Chest (1993) 0.88
Enzyme immunoassay system for panel testing. Clin Chem (1989) 0.87
Dopamine-beta-hydroxylase activity in familial Mediterranean fever. Lancet (1990) 0.86
Pyrin and cryopyrin--similar domain sequence but opposite inflammatory consequence. Clin Exp Rheumatol (2007) 0.86
Antigenic triggers and molecular targets for anti-double-stranded DNA antibodies. Lupus (2002) 0.86
Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients. Hum Immunol (1993) 0.86
Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature. Pharmacopsychiatry (2002) 0.85
About colchicine compliance, resistance and virulence. Clin Exp Rheumatol (2009) 0.85
Syncope: a retrospective study of 101 hospitalized patients. Isr J Med Sci (1985) 0.85
Etiology, treatment, and prognosis of large pericardial effusions. A study of 34 patients. Chest (1991) 0.84
Case series: hyponatremia associated with moderate exercise. Am J Med Sci (1996) 0.84
Colchicine intoxication: clinical pharmacology, risk factors, features, and management. Semin Arthritis Rheum (1991) 0.84
Azoospermia due to testicular amyloidosis in a patient with familial Mediterranean fever. Hum Reprod (2001) 0.84
Colchicine inhibits spermatozoal motility in vitro. Int J Fertil Menopausal Stud (1994) 0.83
Complete heart block and seizures in an adult with systemic lupus erythematosus. A possible pathophysiologic role for anti-SS-A/Ro and anti-SS-B/La autoantibodies. Arthritis Rheum (1993) 0.83
Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature. J Clin Gastroenterol (1997) 0.82
Treatment of lupus nephritis: facing the era of immunotherapy. Panminerva Med (2008) 0.82
FMF - clinical features, new treatments and the role of genetic modifiers: a critical digest of the 2010-2012 literature. Clin Exp Rheumatol (2012) 0.82
Infective endocarditis caused by uncommon bacteria. Scand J Infect Dis (1983) 0.81
Genetic counselling in familial Mediterranean fever: has the time come? Rheumatology (Oxford) (2001) 0.81
Autoantibodies and other biomarkers - pathological consequences (1). Lupus (2008) 0.81
Severe bleeding complicating percutaneous bone marrow biopsy. Arch Intern Med (1984) 0.81
Enigmas in familial Mediterranean fever (FMF). Clin Exp Rheumatol (2001) 0.81
Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature. Clin Exp Rheumatol (2007) 0.81
Aorto-atrial fistula following internal jugular vein catheterization. Eur Heart J (1995) 0.80
CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens (2008) 0.80
Relative incidence of phlebitis associated with peripheral intravenous catheters in the lower versus upper extremities. Eur J Clin Microbiol Infect Dis (2015) 0.79
Mefloquine-induced acute hepatitis. Pharmacotherapy (2000) 0.79
Exacerbation of psoriasis by ibuprofen. Cutis (1986) 0.79
B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus. Arthritis Res (2001) 0.79
Dissecting aortic aneurysm in systemic lupus erythematosus. Lupus (1995) 0.79
Waterborne typhoid fever in Haifa, Israel: clinical, microbiologic, and therapeutic aspects of a major outbreak. Am J Med Sci (1988) 0.78
Azoospermia in familial Mediterranean fever patients: the role of colchicine and amyloidosis. Ann Rheum Dis (1998) 0.78
Familial Mediterranean fever clinical and genetic features in Druzes and in Iraqi Jews: a preliminary study. J Rheumatol (1998) 0.77
Tinnitus due to low-dose aural aspirin therapy. N Engl J Med (1990) 0.77
Inappropriate secretion of antidiuretic hormone in Sheehan's syndrome: a rare cause of postpartum hyponatremia. Am J Obstet Gynecol (1991) 0.77
Optic neuritis associated with familial Mediterranean fever. J Clin Neuroophthalmol (1993) 0.76
Chronic diarrhea--induced by celiac plexus block? J Clin Gastroenterol (1998) 0.76
Lupus refractory pleural effusion: transient response to intravenous immunoglobulins. J Rheumatol (1991) 0.76
Therapeutic approaches to familial Mediterranean fever. What do we know and where are we going to? Clin Exp Rheumatol (2004) 0.76
Poliovaccines and the course of systemic lupus erythematosus--a retrospective study of 73 patients. Vaccine (1992) 0.76
The erythrocyte membranes in beta-thalassemia. Lower sialic acid levels in glycophorin. Biochim Biophys Acta (1980) 0.76
Elective laparoscopic appendectomy in patients with familial Mediterranean fever. World J Surg (1994) 0.76
Total lymphoid irradiation in refractory systemic lupus erythematosus. Ann Intern Med (1986) 0.76
Embryonal germ-layer antigens: target for autoimmunity. Lancet (1992) 0.76
Aprotinin therapy in septic shock. Acta Chir Scand (1989) 0.75
Massive haemothorax from central venous catheterization: a note of caution. Arch Emerg Med (1992) 0.75
Neuropsychiatric involvement in systemic lupus erythematosus. Isr J Med Sci (1992) 0.75
Genotype-phenotype relation and correlation in familial mediterranean fever. Isr Med Assoc J (2001) 0.75
Molecular diagnosis of familial Mediterranean fever. N Engl J Med (2000) 0.75
Glucocorticoid sensitivity in Behçet's disease. Endocr Connect (2012) 0.75
[Current controversies in peer review]. Harefuah (1992) 0.75
[Long term prognosis following adult respiratory distress syndrome]. Harefuah (1992) 0.75
[Sepsis, fibronectin and the reticuloendothelial system]. Harefuah (1991) 0.75
[Toxic methemoglobinemia--due to acute aniline-bromide poisoning]. Harefuah (1983) 0.75
Development of the Abbott MATRIX Aero assay for the measurement of specific IgE. J Immunoassay (1991) 0.75
[Malpositioning of central venous catheters]. Harefuah (1991) 0.75
[Positive end-expiratory pressure and prognosis of the adult respiratory distress syndrome]. Harefuah (1992) 0.75
[Norepinephrine in the therapy of septic shock: a revival?]. Harefuah (1991) 0.75
[Pulmonary artery rupture from the Swan-Ganz catheter: incidence, pathophysiology, treatment, prevention]. Harefuah (1991) 0.75
Problems and conflicts in peer review. Int J Impot Res (1993) 0.75
[New approaches in prevention and treatment of catheter-related sepsis]. Harefuah (1992) 0.75
[Episodic angioedema with eosinophilia]. Harefuah (1993) 0.75
[Corticosteroids in fat embolism syndrome: treatment and prevention]. Harefuah (1991) 0.75
[Conduction defects and arrhythmias as complications of the pulmonary artery (Swan-Ganz) catheter]. Harefuah (1991) 0.75
Target antigens in systemic autoimmune diseases. Isr J Med Sci (1994) 0.75
Pleurodesis for refractory pleural effusion in systemic lupus erythematosus. J Rheumatol (1993) 0.75
Disseminated intravascular coagulation in two patients with histiocytic medullary reticulosis. Am J Clin Pathol (1984) 0.75